title: Early use of autogenous arteriovenous fistula in patients with urgent hemodialysis.
abstract: OBJECTIVE
  This study was designed to evaluate the long-term patency rate and complications associated with early use of the autogenous forearm arteriovenous fistula (AFAVF) in patients needing urgent hemodialysis.
  
  
  METHODS
  The clinical data of all patients undergoing AFAVFs for hemodialysis access between June 1996 and June 2016 were retrospectively evaluated. The primary and secondary patencies were estimated using the life table method.
  
  
  RESULTS
  A total of 104 AFAVFs were created for 102 patients. All patients had entered hemodialysis when fistulas were constructed. The mean time to the first cannulation of the AFAVF was 17.33 ± 4.60 (5-27 days). Four AFAVFs (3.8%) became occluded within 30 days of creation of the access, and five AFAVFs (4.8%) had hematomas after cannulation. There were no cases of infection of the wound or steal syndrome or prolonged arm edema. The primary patency rate was 77.81% at 1 year, 73.05% at 2 years, 64.64% at 3 years, 60.75% at 5 years and 47.48% at 10 years. The secondary patency rate was 96.78% at 1 year, 95.18% at 5 years and 85.81% at 10 years.
  
  
  CONCLUSIONS
  In this study, the patency rates following the early use of the AFAVFs were not inferior to the previously reported patency rates in the literature. For patients entering hemodialysis with an inserted central catheter, the early use of the AFAVFs decreases the complications associated with catheters.
authors.affiliation: Department of Nephrology and Blood Purification Center, Jinan City Central Hospital, Shandong University, No. 105. Jiefang Road, Jinan, 250012, China.
authors.forename: Wanjun
authors.initials: W
authors.lastname: Ren
authors.affiliation: Department of Nephrology and Blood Purification Center, Jinan City Central Hospital, Shandong University, No. 105. Jiefang Road, Jinan, 250012, China.
authors.forename: Huili
authors.initials: H
authors.lastname: Jiang
authors.affiliation: Department of Nephrology and Blood Purification Center, Jinan City Central Hospital, Shandong University, No. 105. Jiefang Road, Jinan, 250012, China.
authors.forename: Yuejuan
authors.initials: Y
authors.lastname: Du
authors.affiliation: Department of Nephrology and Blood Purification Center, Jinan City Central Hospital, Shandong University, No. 105. Jiefang Road, Jinan, 250012, China.
authors.forename: Fang
authors.initials: F
authors.lastname: Liu
authors.affiliation: Department of Nephrology and Blood Purification Center, Jinan City Central Hospital, Shandong University, No. 105. Jiefang Road, Jinan, 250012, China.
authors.forename: Xiaoping
authors.initials: X
authors.lastname: Wang
authors.affiliation: Department of Nephrology, Qianfoshan Hospital, Shandong University, No. 16766. Jingshi Road, Jinan, 250011, Shandong, China. dongmeixk@tom.com.
authors.forename: Dongmei
authors.initials: D
authors.lastname: Xu
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects; D064592:Autografts; D005260:Female; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000209:etiology / Q000601:surgery; D006085:Graft Survival; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012086:Reoperation; D012189:Retrospective Studies; D013997:Time Factors; D014654:Vascular Patency
keywords: Autogenous forearm arteriovenous fistula; Early use; End-stage renal disease; Urgent hemodialysis; Vascular access